Funded by
the European Union
In this interview, Rolf Kaiser, Professor of Virology at the University of Cologne, shares the success of the âLolli-Methodâ, a groundbreaking approach to COVID-19 testing
In this interview, Francesca Incardona, CEO of the EuResist Network, shares insights into the EuCARE project, which was conceived to sustain the mission of schools
At EuCARE, weâre ready to take on the challenges and opportunities of the new year with renewed energy and commitment. đâš This year, weâll continue
On December 10, Federica Bellerba presented findings from the EuCARE school study as a contributed oral presentation at the International Biometric Conference in Atlanta, US.
How do SARS-COV-2 variants, coupled with other factors, influence the short- and long-term clinical course of COVID-19? Is the efficacy of vaccines or diagnostic tests affected as new variants emerge? Does treatment efficacy vary among variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?
34 institutions from 4 continents collaborate to find answers to these and other crucial questions and to create a sustainable network to promptly tackle similar issues in the future.
FUNDED BY THE EC UNDER HORIZON-HLTH-2021-CORONA-01
- GRANT AGREEMENT NO 101046016
Get to know the project and its scope
Find out all the media news about the EuCARE Project.
